Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn/CXCR4 interactions in lipid rafts (Q82063971)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn/CXCR4 interactions in lipid rafts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Y Tabe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

L Jin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

K Iwabuchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

R-Y Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

N Ichikawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

J Cortes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Andreeff

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

M Konopleva

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

18 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

883-892

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22005789%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.291

14 January 2020

exact match

0 references

cites work

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Punish the parent not the progeny.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

BCR-ABL1 alters SDF-1alpha-mediated adhesive responses through the beta2 integrin LFA-1 in leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Integrin inhibition through Lyn-dependent cross talk from CXCR4 chemokine receptors in normal human CD34+ marrow cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Autophosphorylation induces autoactivation and a decrease in the Src homology 2 domain accessibility of the Lyn protein kinase.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Spontaneous autophosphorylation of Lyn tyrosine kinase at both its activation segment and C-terminal tail confers altered substrate specificity.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Roles of C-terminal Src kinase in the initiation and the termination of the high affinity IgE receptor-mediated signaling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Role of glycosphingolipid-enriched microdomains in innate immunity: microdomain-dependent phagocytic cell functions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

PML-RARalpha is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

MDM2 antagonist nutlin-3 displays antiproliferative and proapoptotic activity in mantle cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Lyn, a src-like tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

CXCL12-induced partitioning of flotillin-1 with lipid rafts plays a role in CXCR4 function

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

A lipid raft environment enhances Lyn kinase activity by protecting the active site tyrosine from dephosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

The decreased susceptibility of Bcr/Abl targets to NK cell-mediated lysis in response to imatinib mesylate involves modulation of NKG2D ligands, GM1 expression, and synapse formation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Evidence for a role of glycosphingolipids in CXCR4-dependent cell migration

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Evidence for cell surface association between CXCR4 and ganglioside GM3 after gp120 binding in SupT1 lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

In vitro and in vivo study of cell growth inhibition of simvastatin on chronic myelogenous leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021

Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.291

7 January 2021